A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) (SUPER)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by AHS Cancer Control Alberta.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT01014065
First received: November 12, 2009
Last updated: March 30, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2013
  Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)